Stockreport

Nuvation Bio Inc. (NUVB) Turns Bullish amid Positive Regulatory Trajectory in Europe [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF Wainwright reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a $17 price target. The bullish stance is in response to positive regulatory developments in Eur [Read more]